HeartSciences Inc. WarrantHSCSW
About: HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
Employees: 12
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
45% more capital invested
Capital invested by funds: $16K [Q4 2024] → $23.1K (+$7.18K) [Q1 2025]
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
4.8% less ownership
Funds ownership: 55.84% [Q4 2024] → 51.04% (-4.8%) [Q1 2025]
40% less funds holding
Funds holding: 5 [Q4 2024] → 3 (-2) [Q1 2025]
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Research analyst outlook
We haven’t received any recent analyst ratings for HSCSW.
Financial journalist opinion
We haven’t received any recent news articles for HSCSW.